Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib plus local micro-therapy guided by Gd-EOB-DTPA MRI in inoperable hepatocellular carcinoma
2009-012576-27Phase 2Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatocellular carcinoma (HCC) comparing RFA + sorafenib with RFA + placebo (2 arms). Primary endpoint: Time-to-recurrence (TTR). Started Dec 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2009-012576-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012576-27.